Detalles de la búsqueda
1.
Preclinical evaluation of [225Ac]Ac-DOTA-TATE for treatment of lung neuroendocrine neoplasms.
Eur J Nucl Med Mol Imaging
; 48(11): 3408-3421, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-33772332
2.
Phase 1 trial of dasatinib combined with afatinib for epidermal growth factor receptor- (EGFR-) mutated lung cancer with acquired tyrosine kinase inhibitor (TKI) resistance.
Br J Cancer
; 120(8): 791-796, 2019 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30880334
3.
Randomized-controlled phase II trial of salvage chemotherapy after immunization with a TP53-transfected dendritic cell-based vaccine (Ad.p53-DC) in patients with recurrent small cell lung cancer.
Cancer Immunol Immunother
; 68(3): 517-527, 2019 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-30591959
4.
A Randomized Phase II Study of Linsitinib (OSI-906) Versus Topotecan in Patients With Relapsed Small-Cell Lung Cancer.
Oncologist
; 21(10): 1163-1164, 2016 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-27694157
5.
Genetic Investigation of Uterine Carcinosarcoma: Case Report and Cohort Analysis.
Cancer Control
; 23(1): 61-6, 2016 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-27009459
6.
Propelling Immunotherapy Combinations Into the Clinic.
Oncology (Williston Park)
; 29(12): 990-1002, 2015 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-26680224
7.
Safety and activity of alectinib against systemic disease and brain metastases in patients with crizotinib-resistant ALK-rearranged non-small-cell lung cancer (AF-002JG): results from the dose-finding portion of a phase 1/2 study.
Lancet Oncol
; 15(10): 1119-28, 2014 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-25153538
8.
Current clinical application of genomic and proteomic profiling in non-small-cell lung cancer.
Cancer Control
; 21(1): 32-9, 2014 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-24357739
9.
Beyond the standard of care: a review of novel immunotherapy trials for the treatment of lung cancer.
Cancer Control
; 20(1): 22-31, 2013 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-23302904
10.
A phase I/IB trial of binimetinib in combination with erlotinib in NSCLC harboring activating KRAS or EGFR mutations.
Lung Cancer
; 183: 107313, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37499521
11.
Dose-Limiting Pulmonary Toxicity in a Phase 1/2 Study of Radiation and Chemotherapy with Ipilimumab Followed by Nivolumab for Patients With Stage 3 Unresectable Non-Small Cell Lung Cancer.
Int J Radiat Oncol Biol Phys
; 116(4): 837-848, 2023 Jul 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-36657497
12.
Phase I Study of Taminadenant (PBF509/NIR178), an Adenosine 2A Receptor Antagonist, with or without Spartalizumab (PDR001), in Patients with Advanced Non-Small Cell Lung Cancer.
Clin Cancer Res
; 28(11): 2313-2320, 2022 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35254415
13.
First-in-human study of an OX40 (ivuxolimab) and 4-1BB (utomilumab) agonistic antibody combination in patients with advanced solid tumors.
J Immunother Cancer
; 10(10)2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-36302562
14.
Utilization of target lesion heterogeneity for treatment efficacy assessment in late stage lung cancer.
PLoS One
; 16(7): e0252041, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34197475
15.
Ensartinib vs Crizotinib for Patients With Anaplastic Lymphoma Kinase-Positive Non-Small Cell Lung Cancer: A Randomized Clinical Trial.
JAMA Oncol
; 7(11): 1617-1625, 2021 Nov 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34473194
16.
Tumor-infiltrating lymphocyte treatment for anti-PD-1-resistant metastatic lung cancer: a phase 1 trial.
Nat Med
; 27(8): 1410-1418, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-34385708
17.
A community-based lung cancer rapid tissue donation protocol provides high-quality drug-resistant specimens for proteogenomic analyses.
Cancer Med
; 9(1): 225-237, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31747139
18.
Phase I/II study of atrasentan, an endothelin A receptor antagonist, in combination with paclitaxel and carboplatin as first-line therapy in advanced non-small cell lung cancer.
Clin Cancer Res
; 14(5): 1464-9, 2008 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-18316570
19.
Characterization of epidermal growth factor receptor (EGFR) P848L, an unusual EGFR variant present in lung cancer patients, in a murine Ba/F3 model.
FEBS Open Bio
; 9(10): 1689-1704, 2019 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31314158
20.
A phase I pharmacokinetic and pharmacodynamic study of s-3304, a novel matrix metalloproteinase inhibitor, in patients with advanced and refractory solid tumors.
Clin Cancer Res
; 13(7): 2091-9, 2007 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-17404091